Dystrophin conferral using human endothelium expressing HLA-E in the non-immunosuppressive murine model of duchenne muscular dystrophy

Human Molecular Genetics

Volumn 20, Issue 2, 2011, Pages 235-244

  Cui, Chang Hao ^a,b   Miyoshi, Shunichiro ^c   Tsuji, Hiroko ^c   Makino, Hatsune ^a   Kanzaki, Seiichi ^a   Kami, Daisuke ^a   Terai, Masanori ^a   Suzuki, Harumi ^d   Umezawa, Akihiro ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b MUDANJIANG MEDICAL UNIVERSITY   (China)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; HLA E ANTIGEN; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; DUCHENNE MUSCULAR DYSTROPHY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOMODULATION; LYMPHOCYTE; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; PLACENTAL ARTERY ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

ANIMALS; ARTERIES; CELL CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DYSTROPHIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOCOMPETENCE; MICE; MICE, INBRED BALB C; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCULAR DYSTROPHY, DUCHENNE; RNA, SMALL INTERFERING;

MURINAE; MUS;

EID: 78650529849     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq458     Document Type: Article

References (31)

1. Cossu, G. and Mavilio, F. (2000) Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J. Clin. Invest., 105, 1669-1674.
2. Hoffman, E.P., Brown, R.H. Jr and Kunkel, L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 51, 919-928.
3. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
4. Gerhart, J., Bast, B., Neely, C., Iem, S., Amegbe, P., Niewenhuis, R., Miklasz, S., Cheng, P.F. and George-Weinstein, M. (2001) MyoD-positive myoblasts are present in mature fetal organs lacking skeletal muscle. J. Cell Biol., 155, 381-392.
5. Skuk, D., Goulet, M., Roy, B., Chapdelaine, P., Bouchard, J.P., Roy, R., Dugre, F.J., Sylvain, M., Lachance, J.G., Deschenes, L. et al. (2006) Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol., 65, 371-386.
6. Skuk, D., Goulet, M., Roy, B., Piette, V., Cote, C.H., Chapdelaine, P., Hogrel, J.Y., Paradis, M., Bouchard, J.P., Sylvain, M. et al. (2007) First test of a 'high-density injection' protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up. Neuromuscul. Disord., 17, 38-46.
7. Dezawa, M., Ishikawa, H., Itokazu, Y., Yoshihara, T., Hoshino, M., Takeda, S., Ide, C. and Nabeshima, Y. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science, 309, 314-317.
8. De Bari, C., Dell'Accio, F., Vandenabeele, F., Vermeesch, J.R., Raymackers, J.M. and Luyten, F.P. (2003) Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol., 160, 909-918.
9. Cui, C.H., Uyama, T., Miyado, K., Terai, M., Kyo, S., Kiyono, T. and Umezawa, A. (2007) Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol. Biol. Cell, 18, 1586-1594.
10. Carosella, E.D., Paul, P., Moreau, P. and Rouas-Freiss, N. (2000) HLA-G and HLA-E: fundamental and pathophysiological aspects. Immunol. Today, 21, 532-534.
11. Ulbrecht, M., Honka, T., Person, S., Johnson, J.P. and Weiss, E.H. (1992) The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein. J. Immunol., 149, 2945-2953.
12. Braud, V.M., Allan, D.S., O'Callaghan, C.A., Soderstrom, K., D'Andrea, A., Ogg, G.S., Lazetic, S., Young, N.T., Bell, J.I., Phillips, J.H. et al. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature, 391, 795-799.
13. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M. and Geraghty, D.E. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl Acad. Sci. USA, 95, 5199-5204.
14. Borrego, F., Ulbrecht, M., Weiss, E.H., Coligan, J.E. and Brooks, A.G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med., 187, 813-818.
15. Tsuji, H., Miyoshi, S., Ikegami, Y., Hida, N., Asada, H., Togashi, I., Suzuki, J., Satake, M., Nakamizo, H., Tanaka, M. et al. (2010) Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ. Res., 106, 1613-1623.
16. Coupel, S., Moreau, A., Hamidou, M., Horejsi, V., Soulillou, J.P. and Charreau, B. (2007) Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood, 109, 2806-2814.
17. Faustman, D. and Coe, C. (1991) Prevention of xenograft rejection by masking donor HLA class I antigens. Science, 252, 1700-1702.
18. Mendell, J.R., Kissel, J.T., Amato, A.A., King, W., Signore, L., Prior, T.W., Sahenk, Z., Benson, S., McAndrew, P.E., Rice, R. et al. (1995) Myoblast transfer in the treatment of Duchenne'smuscular dystrophy. N. Engl. J.Med., 333, 832-838.
19. Mori, T., Kiyono, T., Imabayashi, H., Takeda, Y., Tsuchiya, K., Miyoshi, S., Makino, H., Matsumoto, K., Saito, H., Ogawa, S. et al. (2005) Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Mol. Cell. Biol., 25, 5183-5195.
20. Li, J., Goldstein, I., Glickman-Nir, E., Jiang, H. and Chess, L. (2001) Induction of TCR Vbeta-specific CD8+ CTLs by TCR Vbeta-derived peptides bound to HLA-E. J. Immunol., 167, 3800-3808.
21. Hu, D., Ikizawa, K., Lu, L., Sanchirico, M.E., Shinohara, M.L. and Cantor, H. (2004) Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol., 5, 516-523.
22. Bryan, B.A., Walshe, T.E., Mitchell, D.C., Havumaki, J.S., Saint-Geniez, M., Maharaj, A.S., Maldonado, A.E. and D'Amore, P.A. (2008) Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation. Mol. Biol. Cell, 19, 994-1006.
23. Darabi,R., Gehlbach,K., Bachoo, R.M.,Kamath, S.,Osawa,M., Kamm, K.E., Kyba,M. and Perlingeiro, R.C. (2008) Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat. Med., 14, 134-143.
24. Friedenstein, A.J., Gorskaja, J.F. and Kulagina, N.N. (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol., 4, 267-274.
25. Bieback, K., Kern, S., Kluter, H. and Eichler, H. (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22, 625-634.
26. In 't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., de Groot-Swings, G.M., Claas, F.H., Fibbe, W.E. and Kanhai, H.H. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells, 22, 1338-1345.
27. In 't Anker, P.S., Scherjon, S.A., Kleijburg-van der Keur, C., Noort, W.A., Claas, F.H., Willemze, R., Fibbe, W.E. and Kanhai, H.H. (2003) Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood, 102, 1548-1549.
28. Prockop, D.J. (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276, 71-74.
29. Kohyama, J., Abe, H., Shimazaki, T., Koizumi, A., Nakashima, K., Gojo, S., Taga, T., Okano, H., Hata, J. and Umezawa, A. (2001) Brain from bone: efficient 'meta-differentiation' of marrow stroma-derived mature osteoblasts to neurons with Noggin or a demethylating agent. Differentiation, 68, 235-244.
30. Horwitz, E.M., Gordon, P.L., Koo, W.K., Marx, J.C., Neel, M.D., McNall, R.Y., Muul, L. and Hofmann, T. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl Acad. Sci. USA, 99, 8932-8937.
31. Miyoshi, H., Takahashi, M., Gage, F.H. and Verma, I.M. (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl Acad. Sci. USA, 94, 10319-10323.